Our study revealed that exo-linc-FAM138B secreted by cancer cells inhibited HCC development via targeting miR-765, which provided a new idea and perspective for in-depth understanding of the complex signal regulation in HCC process. The gene discussed is FAM138B; the disease is hepatocellular carcinoma.